Search results
Results from the WOW.Com Content Network
UpToDate, Inc. is a company in the Wolters Kluwer Health division of Wolters Kluwer, the main product of which is the eponymous UpToDate, a software system that is a point-of-care medical resource. The UpToDate system is an evidence-based clinical resource. It includes a collection of medical and patient information, access to Lexicomp drug ...
Optune was approved by the FDA for newly diagnosed glioblastoma on Oct. 5, 2015, [31] as a result of randomized phase 3 trial results that reported a 3-month advantage in overall survival and progression-free survival when added to chemotherapy with temozolomide. [23] [24] In the US, Medicare covers treatment, as of February 2020. [32]
Alexandra Elbakyan at a conference at Harvard (2010). Sci-Hub was created by Alexandra Elbakyan, who was born in Kazakhstan in 1988. [22] Elbakyan earned her undergraduate degree at Kazakh National Technical University [23] studying information technology, then worked for a year for a computer security firm in Moscow, then joined a research team at the University of Freiburg in Germany in 2010 ...
The most common side effects of tafasitamab are low blood cell counts, fatigue, diarrhea, cough, fever, limb swelling, upper respiratory infection, and decreased appetite. [7] Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody. [5][8] Tafasitamab was approved for medical use in the United States in July 2020, [7][8][9] and in the ...
The trial measured the average number of cluster headaches per week for three weeks and compared the average changes from baseline in the galcanezumab and placebo groups. [6] During the three-week period, participants taking galcanezumab experienced 8.7 fewer weekly cluster headache attacks than they did at baseline, compared to 5.2 fewer ...
Voxelotor. Voxelotor, sold under the brand name Oxbryta, is a medication used for the treatment of sickle cell disease. [1][3][4][5][6] Voxelotor is the first hemoglobin oxygen-affinity modulator. [7] Voxelotor has been shown to have disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators in sickle cell ...
Burton Rose was a clinical professor of medicine at Harvard University. [3] He also held positions at the University of Massachusetts Medical School, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center. [2] He was the author of Clinical Physiology of Acid-Base and Electrolyte Disorders and Pathophysiology of Renal Disease ...
For example, UpToDate was created in the early 1990s. [51] The Cochrane Collaboration began publishing evidence reviews in 1993. [ 42 ] In 1995, BMJ Publishing Group launched Clinical Evidence, a 6-monthly periodical that provided brief summaries of the current state of evidence about important clinical questions for clinicians.